$IDXX News
Last published 1w ago
- 1w agoIDXXIDEXX LABORATORIES INC /DE - EXHIBIT 99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1mo agoIDXXIDEXX Laboratories to Release 2026 Third Quarter Financial ResultsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 third quarter financial results for Monday, November 2, 2026, before the market opens. The
- 1mo agoIDXXIDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm DetectionBusiness WireExpanded testing menu now detects more intestinal parasites during routine visits IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Faecal Dx™
- 1mo agoIDXXIDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow IntelligenceBusiness WireAcquisition strengthens IDEXX’s connected diagnostic and software ecosystem with AI-native workflow capabilities that enhance efficiency, clinical decision-making, and diagnostic utilization IDEXX Laboratories, Inc.
- 1mo agoIDXXIDEXX Laboratories, Inc. - 1773598 - IDEXX LABORATORIES INCEarnings Call TranscriptsHi. Good morning slash afternoon to folks. Welcome to the Morgan Stanley Global Healthcare Conference. My name is Erin Wright. I'm the Lead Healthcare Services Analyst at Morgan Stanley. We're happy to have IDEXX Laborat
- 2mo agoIDXXIDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare ConferenceBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, and Andrew Emerson, Executive Vice President and Chief
- 3mo agoIDXXIDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP TestBusiness WireNew test brings quantitative cardiac assessment for cats and dogs into everyday workflows IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced the launch of the
- 3mo agoIDXXIDEXX Laboratories Announces Second Quarter ResultsBusiness WireAchieves second quarter revenue growth of 10% as reported and 9% organic, and CAG Diagnostics recurring revenue growth of 11% as reported and 10% organic. Strong volume-driven CAG Diagnostics recurring revenue
- 3mo agoIDXXIDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its GoalsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today released its 2025 Corporate Responsibility Report, highlighting progress against the company’s goals and commitments. This
- 3mo agoNES.N-CHNVOLLYCL+5Fat cat? Weight-loss drugs may be coming for your overweight petCNBCStartups are testing GLP-1 treatments for overweight cats while pet-food giants are leaning into longevity products as owners spend more on animal health.
- 4mo agoIDXXIDEXX Laboratories to Release 2026 Second Quarter Financial ResultsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 second quarter financial results for Tuesday, August 4, 2026, before the market opens. The
- 5mo agoIDXXIDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm DetectionBusiness WireThird menu expansion in four years broadens intestinal parasite detection in routine care IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced the expansion of its
- 5mo agoIDXXIDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry ProfilesBusiness WireBuilt-in SDMA delivers earlier insights with seamless workflow IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced that SDMA, a renal biomarker, will be built into
- 5mo agoARGXCGEMHYFTIDXX+2The Biology Came First.Business WireOver 20 partner-owned drug programs have reached clinical trials as a result of antibody discovery work performed by MindWalk scientists — ten currently in active Phase 1–3. The same scientific depth and biological
- 6mo agoIDXXIDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor DayBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, will participate in a fireside chat at the Stifel Jaws
- 6mo agoSPCETSLAHFIGS+22Baron First Principles ETF | Q2 2026Baron Capital Group
- 6mo agoIDXXIDEXX Laboratories Announces First Quarter ResultsBusiness WireAchieves first quarter revenue growth of 14% as reported and 11% organic, and CAG Diagnostics recurring revenue growth of 14% as reported and 11% organic. Double-digit organic revenue growth was driven by IDEXX
- 7mo agoIDXXIDEXX Laboratories to Release 2026 First Quarter Financial ResultsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 first quarter financial results for Tuesday, May 5, 2026, before the market opens. The Company
- 7mo agoIDXXIDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine LymphomaBusiness WireHelping clinicians investigate sooner and plan next steps with confidence IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced the availability of the IDEXX Cancer
- 7mo agoVRSKBIRKMTNFDS+22Dear Baron First Principles ETF® ShareholderBaron Capital Group
- 9mo agoIDXXIDEXX Laboratories to Present at Two Institutional Investor ConferencesBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 26, 9:55 am – 10:30 am EST – Mike Lane, Executive Vice President
- 9mo agoIDXXIDEXX Laboratories Announces Fourth Quarter and Full Year 2025 ResultsBusiness WireAchieves fourth quarter revenue growth of 14% as reported and 12% organic, reflecting strong CAG Diagnostics recurring revenue, growing 12% reported and 10% organic. Strong organic growth benefits from IDEXX
- 1y agoIDXXIDEXX Laboratories Announces Third Quarter ResultsBusiness WireAchieves third quarter revenue growth of 13% as reported and 12% organic, and CAG Diagnostics recurring revenue growth of 11% as reported and 10% organic. Strong organic revenue growth was supported by IDEXX
- 1y agoIDXXBonsai Health Names ModMed Veteran Rick Trefzger Chief Revenue OfficerBusiness WireFormer Modernizing Medicine sales leader joins Bonsai to accelerate growth of its agentic AI platform for healthcare practices. Bonsai Health, the agentic AI platform automating complex healthcare workflows, today
- 1y agoIDXXIDEXX Laboratories to Release 2025 Third Quarter Financial ResultsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 third quarter financial results for Monday, November 3, 2025, before the market opens. The
- 1y agoIDXXIDEXX Laboratories Elects Karen Peacock to Board of DirectorsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced the election of Karen Peacock to the Company's Board of Directors, effective October 6, 2025. "We are
- 1y agoIDXXIDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
- 1y agoIDXXIDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare ConferenceBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and Andrew Emerson, Executive Vice President and Chief
- 1y agoIDXXIDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoIDXXIDEXX Laboratories Announces Second Quarter ResultsBusiness WireAchieves second quarter revenue growth of 11% as reported and 9% organic, supported by CAG Diagnostics recurring revenue growth of 9% as reported and 7% organic. Advances IDEXX's innovation agenda and continues
- 1y agoIDXXIDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its GoalsPR NewswireIDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today released its 2024 Corporate Responsibility Report...
- 1y agoIDXXIDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of DirectorsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced the election of Joseph L. (Jay) Hooley to the Company's Board of Directors, effective July 10, 2025. "We
- 1y agoIDXXIDEXX Laboratories to Release 2025 Second Quarter Financial ResultsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 second quarter financial results for Monday, August 4, 2025, before the market opens. The
- 1y agoIDXXThird Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine DisordersPR NewswireIDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst® Cortisol Test,...
- 1y agoIDXXIDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor DayBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced that Andrew Emerson, Executive Vice President and Chief Financial Officer, and Tina Hunt, Executive Vice President,
- 1y agoIDXXIDEXX Laboratories Announces First Quarter ResultsBusiness WireAchieves first quarter revenue growth of 4% as reported and 5% organic, supported by CAG Diagnostics recurring revenue growth of 3% as reported and 4.5% organic. Organic revenue growth supported by benefits from
- 1y agoIDXXIDEXX Laboratories to Release 2025 First Quarter Financial ResultsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 first quarter financial results for Thursday, May 1, 2025, before the market opens. The Company
- 1y agoIDXXIDEXX Laboratories to Present at Two Upcoming Institutional Investor ConferencesBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 27, 9:05 am – 9:45 am EST – Mike Erickson, PhD, Executive Vice
- 1y agoIDXXIDEXX Laboratories Announces Fourth Quarter and Full Year 2024 ResultsBusiness WireAchieves fourth quarter revenue growth of 6% as reported and on an organic basis, driven by CAG Diagnostics recurring revenue growth of 6% reported and 7% organic Solid growth supported by continued benefits from
- 1y agoIDXXIDEXX Announces Groundbreaking Cancer Dx Panel with Affordable Early Detection Test for Canine LymphomaPR NewswireIDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of IDEXX Cancer Dx™, a...
- 1y agoIDXXIDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial ResultsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025, before the market
- 1y agoIDXXSNPSSR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXXGlobeNewswireBOSTON, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Sustainability Roundtable, Inc. (SR Inc), a leader in strategic advisory and support services, proudly announces the recipients of its 2024 Sustainable Business &
- 1y agoIDXXIDEXX Laboratories Announces Increase in Share Repurchase Program AuthorizationBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced that the Company's Board of Directors authorized an increase in its ongoing share repurchase program, authorizing the
- 1y agoIDXXIDEXX Announces CFO TransitionBusiness WireBrian McKeon to Retire from IDEXX in June 2025 Andrew Emerson, Senior Vice President, Corporate and CAG Finance, to Serve as IDEXX's Next CFO IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare
- 2y agoIDXXIDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoIDXXIDEXX Laboratories Announces Third Quarter ResultsBusiness WireAchieves third quarter revenue growth of 7% as reported and 6% organic, supported by CAG Diagnostics recurring revenue growth of 7% as reported and organic. Organic revenue growth supported by benefits from IDEXX
- 2y agoIDXXIDEXX Laboratories to Release 2024 Third Quarter Financial ResultsBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 third quarter results for Thursday, October 31, 2024, before the market opens. The Company will
- 2y agoIDXXIDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare ConferenceBusiness WireIDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief
- 2y agoIDXXIDEXX Laboratories, Inc. (IDXX) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoIDXXIDEXX Laboratories Announces Second Quarter ResultsBusiness WireAchieves second quarter revenue growth of 6% as reported and 7% organic, supported by CAG Diagnostics recurring revenue growth of 6% as reported and 7% organic. Solid growth supported by continued benefits from